Moreover, studies indicates that as insulin resistance and OS progresses, FoxO1 acts to combat these conditions but over time its protein levels decline causing β-cell dedifferentiation and marking a molecular switch to T2D pathology (165, 166). This evidence concerns the gene FOXO1 and Insulin resistance.